U .S. taxpayers spent an estimated $6 billion researching, developing, and implementing new blockbuster weight-loss drugs, according to new data shared with The Lever. Yet Americans are now paying pharmaceutical giants — including one in Denmark — up to 11 times more for these medicines than patients in other countries, markups that are inflating consumers’ insurance premiums and risk bankrupting the country’s health care system.
It’s unclear whether President Donald Trump will crack down on weight-loss drug price gouging. While Biden regulators selected two top-selling weight-loss medications for Medicare price negotiations this year, potentially lowering their price for millions of Americans, Trump has sent mixed messages about the future of price-negotiation programs and nominated people who’ve sold or promoted weight-loss drugs to oversee related matters.
Novo Nordisk isn't a "corporation"....it's far more sneaky.....it's a "foundation". "not for profit" as in Political Action Committee.......just think of the grift possibilitiies and political conflicts of interest possible in this Danish deep state stroke of genius!